Cholic acid-mediated targeting of mRNA-LNPs improve the mRNA delivery to Caco-2 cells

1. Ye Z, Harmon J, Ni W, Li Y, Wich D, Xu Q (2023) The mRNA vaccine revolution: COVID-19 has launched the future of vaccinology. ACS Nano 17(16):15231–1525310.1021/acsnano.2c12584 ↗

2. Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, Kranz LM, Diken M, Kreiter S, Haas H, Attig S, Rae R, Cuk K, Kemmer-Bruck A, Breitkreuz A, Tolliver C, Caspar J, Quinkhardt J, Hebich L, Stein M, Hohberger A, Vogler I, Liebig I, Renken S, Sikorski J, Leierer M, Muller V, Mitzel-Rink H, Miederer M, Huber C, Grabbe S, Utikal J, Pinter A, Kaufmann R, Hassel JC, Loquai C, Tureci O (2020) An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature10.1038/s41586-020-2537-9 ↗

3. Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6(12):1078–109410.1038/s41578-021-00358-0 ↗

4. Mukai H, Ogawa K, Kato N, Kawakami S (2022) Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics. Drug Metab Pharmacokinet 44:10045010.1016/j.dmpk.2022.100450 ↗

5. Curreri A, Sankholkar D, Mitragotri S, Zhao Z (2023) RNA therapeutics in the clinic. Bioeng Transl Med 8(1):e1037410.1002/btm2.10374 ↗

6. He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W (2019) Adapting liposomes for oral drug delivery. Acta Pharm Sin B 9(1):36–4810.1016/j.apsb.2018.06.005 ↗

7. Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, Jayaprakash KN, Jayaraman M, Rajeev KG, Cantley WL, Dorkin JR, Butler JS, Qin L, Racie T, Sprague A, Fava E, Zeigerer A, Hope MJ, Zerial M, Sah DWY, Fitzgerald K, Tracy MA, Manoharan M, Koteliansky V, Fougerolles AD, Maier MA (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Molecular Therapy 18(7): 1357–136410.1038/mt.2010.85 ↗

8. Green PHR, Glickman RM (1981) Intestinal lipoprotein metabolism. J Lipid Res 22:1153–117310.1016/S0022-2275(20)37308-9 ↗

9. Deng F, Bae YH (2020) Bile acid transporter-mediated oral drug delivery. J Control Release 327:100–11610.1016/j.jconrel.2020.07.034 ↗

10. Alam F, Al-Hilal TA, Chung SW, Seo D, Mahmud F, Kim HS, Kim SY, Byun Y (2014) Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid. Biomaterials 35(24):6543–655210.1016/j.biomaterials.2014.04.050 ↗

11. Li Y, Zhu C (2016) Enhanced hepatic-targeted delivery via oral administration using nanoliposomes functionalized with a novel DSPE–PEG–cholic acid conjugate. RSC Adv 6(33):28110–2812010.1039/C5RA28018D ↗

12. Patel SK, Billingsley MM, Mukalel AJ, Thatte AS, Hamilton AG, Gong N, El-Mayta R, Safford HC, Merolle M, Mitchell MJ (2024) Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery. Theranostics 14(1):1–1610.7150/thno.89913 ↗

13. Zhang EY, Phelps MA, Banerjee A, Khantwal CM, Chang C, Helsper F, Swaan PW (2004) Topology scanning and putative three-dimensional structure of the extracellular binding domains of the apical sodium-dependent bile acid transporter (SLC10A2). Biochemistry 43(36):11380–1139210.1021/bi049270a ↗

14. Kramer W, Girbig F, Glombik H, Corsiero D, Stengelin S, Weyland C (2001) Identification of a ligand-binding site in the Na+/bile acid cotransporting protein from rabbit ileum*. J Biol Chem 276(38):36020–3602710.1074/jbc.M104665200 ↗

15. Kang MJ, Park SH, Kang MH, Park MJ, Choi YW (2013) Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation. Int J Nanomedicine 8:1155–116510.2217/nnm.13.104 ↗

16. Deng F, Kim KS, Moon J, Bae YH (2022) Bile acid conjugation on solid nanoparticles enhances ASBT-mediated endocytosis and chylomicron pathway but weakens the transcytosis by inducing transport flow in a cellular negative feedback loop. Adv Sci 9(21):220141410.1002/advs.202201414 ↗

17. Alrefai WA, Sarwar Z, Tyagi S, Saksena S, Dudeja PK, Gill RK (2005) Cholesterol modulates human intestinal sodium-dependent bile acid transporter. Am J Physiol Gastrointest Liver Physiol 288(5):G978–G98510.1152/ajpgi.00379.2004 ↗

18. Wright L, Barnes TJ, Joyce P, Prestidge CA (2022) Optimisation of a high-throughput model for mucus permeation and nanoparticle discrimination using biosimilar mucus. Pharmaceutics 14(12):265910.3390/pharmaceutics14122659 ↗

19. Belliveau NM, Huft J, Lin PJC, Chen S, Leung AKK, Leaver TJ, Wild AW, Lee JB, Taylor RJ, Tam YK, Hansen CL, Cullis PR (2012) Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA. Mol. Ther. Nucleic Acids. 110.1038/mtna.2012.28 ↗

20. Al-Hilal TA, Chung SW, Alam F, Park J, Lee KE, Jeon H, Kim K, Kwon IC, Kim I-S, Kim SY, Byun Y (2014) Functional transformations of bile acid transporters induced by high-affinity macromolecules. Sci Rep 4(1):416310.1038/srep04163 ↗

21. Lai SK, O’Hanlon DE, Harrold S, Man ST, Wang Y-Y, Cone R, Hanes J (2007) Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 104(5):1482–148710.1073/pnas.0608611104 ↗

22. De Leo V, Milano F, Mancini E, Comparelli R, Giotta L, Nacci A, Longobardi F, Garbetta A, Agostiano A, Catucci L (2018) Encapsulation of curcumin-loaded liposomes for colonic drug delivery in a pH-responsive polymer cluster using a pH-driven and organic solvent-free process. Molecules 23(4):73910.3390/molecules23040739 ↗

23. Alghurabi H, Tagami T, Ogawa K, Ozeki T (2022) Preparation, characterization and in vitro evaluation of Eudragit S100-coated bile salt-containing liposomes for oral colonic delivery of Budesonide. Polymers 14(13):269310.3390/polym14132693 ↗

24. Ribbons KA, Thompson JH, Liu X, Pennline K, Clark DA, Miller MJS (1997) Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur J Pharmacol 323(2):245–25410.1016/S0014-2999(97)00017-4 ↗